Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab
نویسندگان
چکیده
منابع مشابه
269 Refractory Chronic Urticaria Treated with Omalizumab
269 Refractory Chronic Urticaria Treated with Omalizumab Martinez Saenz, NP, Ramírez Del Pozo, ME, Lopez Tiro JJ, and Javier Gomez Vera, MD. Alergia e inmunologia clínica, Hospital Regional Lic. Adolfo Lopez Mateos, Distrito Federal, Mexico. Background: Chronic urticaria (CU) is a common disorder characterized by recurrent episodes of urticaria pruritic erythematous lesions, associated with ang...
متن کاملLong-term treatment of refractory severe chronic urticaria by omalizumab: analysis of two cases
Address for correspondence: Prof. Luigi Macchia MD, PhD, Department and School of Allergology and Clinical Immunology, University of Bari – Aldo Moro, Piazza Giulio Cesare, Policlinico, 70124 Bari, Italy, phone: +39 080 5478817, fax: +39 080 5593688, e-mail: [email protected] Received: 30.01.2014, accepted: 29.04.2014 Long-term treatment of refractory severe chronic urticaria by omalizumab...
متن کاملChronic idiopathic urticaria: treatment with omalizumab.
Chronic idiopathic urticaria (CIU) is a common autoimmune skin condition characterized by spontaneously recurring hives for 6 weeks or longer. The new terminology used for CIU in most countries including Canada is chronic spontaneous urticaria (CSU). CSU is associated with significant psychosocial morbidity with a markedly negative impact on overall quality of life. Conventional approaches with...
متن کاملEffects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
PURPOSE Chronic urticaria (CU) is a common and debilitating disease, and the need for effective treatment has increased. Omalizumab may be an alternative regimen in patients with CU who do not respond to conventional treatments. The aim of this study is to investigate the efficacy and to observe the clinical results of omlizumab in patients with refractory CU. METHODS We conducted a retrospec...
متن کاملCost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey.
PSS3 CoSt-EffECtivEnESS of omalizumab in ChroniC idioPathiC urtiCaria rEfraCtory to h1-antihiStaminES in turkEy Tatar M.1, Sezen S.2, Senturk A.3, Balp M.M.4, Saylan M.2, Keskinaslan A.2 1Hacettepe University, Ankara, Turkey, 2Novartis Pharma, Istanbul, Turkey, 3Polar Polar Health Economics & Policy, Ankara, Turkey, 4Novartis Pharma AG, Basel, Switzerland Objectives: Omalizumab is a humanised a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Dermato Venereologica
سال: 2010
ISSN: 0001-5555
DOI: 10.2340/00015555-0884